doxifluridine has been researched along with Cancer of Prostate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eliason, J; Hussain, M; Li, R; Li, Y; Sarkar, FH; Sarkar, SH | 1 |
| Ciccolini, J; Ferrero, JM; Fischel, JL; Formento, JL; Formento, P; Milano, G; Renée, N | 1 |
| Honda, J; Kai, N; Kikuchi, K; Kikukawa, H; Kuwahara, T; Matsumoto, K; Nakanishi, J; Takahashi, W; Ueda, S; Wada, Y | 1 |
| Creaven, PJ; Madajewicz, S; Mittelman, A | 1 |
| Akebi, N; Josen, T; Kobashi, K; Matsumura, Y; Nanba, K; Nasu, Y; Ochi, J; Ohmori, H; Saika, T; Tanahashi, T | 1 |
1 review(s) available for doxifluridine and Cancer of Prostate
| Article | Year |
|---|---|
New potential treatment modalities for disseminated prostatic cancer.
Topics: Androgen Antagonists; Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Castration; Combined Modality Therapy; Cyclophosphamide; Floxuridine; Folic Acid Antagonists; Hormones; Humans; Interferons; Isomerism; Male; Methotrexate; Naphthacenes; Nitrosourea Compounds; Organoplatinum Compounds; Prostatic Neoplasms; Thymus Hormones; Tumor Stem Cell Assay | 1984 |
1 trial(s) available for doxifluridine and Cancer of Prostate
| Article | Year |
|---|---|
Docetaxel, low-dose estramustine, and doxifluridine in hormone-refractory metastatic prostate cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Estramustine; Floxuridine; Granulocyte Colony-Stimulating Factor; Humans; Japan; Male; Middle Aged; Neutropenia; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Survival Rate; Taxoids | 2008 |
3 other study(ies) available for doxifluridine and Cancer of Prostate
| Article | Year |
|---|---|
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Docetaxel; Floxuridine; Gene Expression; Gene Expression Profiling; Humans; Male; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Taxoids | 2005 |
Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Docetaxel; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Floxuridine; Humans; Male; Prostatic Neoplasms; Taxoids; Thymidine Phosphorylase; Thymidylate Synthase | 2005 |
[Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anorexia; Antineoplastic Agents; Diarrhea; Drug Administration Schedule; Female; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Multicenter Studies as Topic; Nausea; Prostatic Neoplasms; Urinary Bladder Neoplasms | 1991 |